IL122445A - Peptide polymers and pharmaceutical compositions comprising them for treatment of myasthenia gravis - Google Patents

Peptide polymers and pharmaceutical compositions comprising them for treatment of myasthenia gravis

Info

Publication number
IL122445A
IL122445A IL12244593A IL12244593A IL122445A IL 122445 A IL122445 A IL 122445A IL 12244593 A IL12244593 A IL 12244593A IL 12244593 A IL12244593 A IL 12244593A IL 122445 A IL122445 A IL 122445A
Authority
IL
Israel
Prior art keywords
treatment
myasthenia gravis
pharmaceutical compositions
amino acid
peptides
Prior art date
Application number
IL12244593A
Other languages
English (en)
Inventor
Edna Mozes
Michael Sela
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of IL122445A publication Critical patent/IL122445A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12244593A 1992-06-18 1993-06-18 Peptide polymers and pharmaceutical compositions comprising them for treatment of myasthenia gravis IL122445A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90039392A 1992-06-18 1992-06-18
IL10606593A IL106065A (en) 1992-06-18 1993-06-18 Synthetic peptides for the treatment of myasthenia gravis and preparations containing them

Publications (1)

Publication Number Publication Date
IL122445A true IL122445A (en) 2000-08-31

Family

ID=25412446

Family Applications (3)

Application Number Title Priority Date Filing Date
IL12244593A IL122445A (en) 1992-06-18 1993-06-18 Peptide polymers and pharmaceutical compositions comprising them for treatment of myasthenia gravis
IL10606593A IL106065A (en) 1992-06-18 1993-06-18 Synthetic peptides for the treatment of myasthenia gravis and preparations containing them
IL12244597A IL122445A0 (en) 1992-06-18 1993-06-18 Peptide polymers and pharmaceutical compositions comprising them for treatment of myasthenia gravis

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL10606593A IL106065A (en) 1992-06-18 1993-06-18 Synthetic peptides for the treatment of myasthenia gravis and preparations containing them
IL12244597A IL122445A0 (en) 1992-06-18 1993-06-18 Peptide polymers and pharmaceutical compositions comprising them for treatment of myasthenia gravis

Country Status (11)

Country Link
EP (1) EP0646016B1 (de)
JP (1) JP3996635B2 (de)
AT (1) ATE183652T1 (de)
AU (1) AU678372B2 (de)
CA (1) CA2138258C (de)
DE (1) DE69326145T2 (de)
DK (1) DK0646016T3 (de)
ES (1) ES2139667T3 (de)
GR (1) GR3031371T3 (de)
IL (3) IL122445A (de)
WO (1) WO1994000148A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6066621A (en) * 1989-12-10 2000-05-23 Yeda Research And Development Co. Ltd. Synthetic peptides for the treatment of myasthenia gravis
US5843462A (en) * 1995-11-30 1998-12-01 Regents Of The University Of Minnesota Diphtheria toxin epitopes
EP1037663A2 (de) 1997-12-16 2000-09-27 Regents Of The University Of Minnesota Verfahren zur behandlung unerwünschter immunantworten
JP2003521448A (ja) 1998-07-23 2003-07-15 ザ・プレジデント・アンド・フェローズ・オブ・ハーバード・カレッジ 合成ペプチドおよび自己免疫疾患治療のための使用方法
WO2022260579A2 (en) 2021-06-07 2022-12-15 Toleranzia Ab Fusion protein in myasthenia gravis
WO2024206202A1 (en) * 2023-03-24 2024-10-03 Cour Pharmaceuticals Development Company Inc. Tolerizing immune modifying nanoparticles for myasthenia gravis treatment

Also Published As

Publication number Publication date
IL122445A0 (en) 1998-06-15
IL106065A0 (en) 1993-10-20
JP3996635B2 (ja) 2007-10-24
ES2139667T3 (es) 2000-02-16
EP0646016A4 (de) 1995-07-12
EP0646016A1 (de) 1995-04-05
DE69326145T2 (de) 2000-04-27
DK0646016T3 (da) 2000-03-20
WO1994000148A1 (en) 1994-01-06
AU678372B2 (en) 1997-05-29
CA2138258C (en) 2003-08-19
DE69326145D1 (de) 1999-09-30
EP0646016B1 (de) 1999-08-25
GR3031371T3 (en) 2000-01-31
JPH07508521A (ja) 1995-09-21
ATE183652T1 (de) 1999-09-15
AU4642993A (en) 1994-01-24
CA2138258A1 (en) 1994-01-06
IL106065A (en) 1999-10-28

Similar Documents

Publication Publication Date Title
DE68916932D1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
ATE415173T1 (de) Pan dr-bindeproteinen zur erhöhung der immunantwort
NZ234586A (en) Peptide of a t-cell receptor capable of inducing protection from immune-related disease
AU9315398A (en) Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
IE891542L (en) Peptides having t cell helper activity
EP1440980A3 (de) Peptidanaloge des menschlichen, basischen Myelinproteins
WO2004089280A3 (en) Reversible pegylated drugs
WO2001018035A3 (en) Muc-1 derived peptides
CA2185826A1 (en) Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases
SI0820303T1 (en) PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES
GB9219936D0 (en) Vaccines
HUT69169A (en) T-cell-suppressive peptide fragments of human myelin basic protein (hmbp) and pharmaceutical compositions containing them
IL81833A (en) Renin inhibitory peptides,their preparation and pharmaceutical compositions containing them
IL122445A0 (en) Peptide polymers and pharmaceutical compositions comprising them for treatment of myasthenia gravis
BR0312889A (pt) Polipeptìdeo t20 peguilado
IL122443A0 (en) Synthetic peptides and pharmaceutical compositions comprising them
BR9707142A (pt) Polinucleotìdeo purificado, dna, vetor, célula hospedeira, linhagem celular de hibridoma, anticorpo monoclonal, processos para produzir exodus, para aumentar a resistência à infecção por vìrus de imonudeficiência humana (hiv), para tratamento de infecção por vìrus de imonodeficiência humana (hiv), para proteção de células progenitoras de medula óssea contra os efeitos citotóxicos e para tratamento de doenças mieloproliferativas, e, uso de produto de proteina de exodus.
WO2000065028A3 (en) TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR
GR3035386T3 (en) Pharmaceutical preparation based on Clara cell protein CC10, and it's use as medicament and diagnosticum.
CA2163212A1 (en) Therapeutic compounds
RU95120588A (ru) Циклогексапептиды, их смеси, способ их получения и применения
CA2459811A1 (en) Modified peptides and their use for the treatment of autoimmune diseases
CA2057612A1 (en) Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof
ZA882641B (en) Human rhinovirus peptides
AU6977994A (en) Peptides derived from human interleukin-2 for use in medicine

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees